TG Therapeutics Competitors and Similar CompaniesClear all
TG Therapeutics's competitors and similar companies include CSL Behring and Biogen.
 TG Therapeutics TG Therapeutics is a biopharmaceutical company, which develops agents for the treatment of hematologic malignancies and autoimmune disorders. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 1993 | Founding Date 1904 | Founding Date 1978 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations New York, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 15314% increase | Employees 7,5692% decrease | Employees 7,605 |
Valuation ($) | Valuation ($) 4 b | Valuation ($) N/A | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) $616.3m (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods $100.7m (FY, 2025) | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit $515.6m (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) |
Net income | Net income $447.2m (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company